BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 31559537)

  • 1. Decreased expression of microRNAs targeting type-2 diabetes susceptibility genes in peripheral blood of patients and predisposed individuals.
    Kokkinopoulou I; Maratou E; Mitrou P; Boutati E; Sideris DC; Fragoulis EG; Christodoulou MI
    Endocrine; 2019 Nov; 66(2):226-239. PubMed ID: 31559537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-based analysis of 84 microRNAs identifies molecules deregulated in individuals with type-2 diabetes, risk factors for the disease or metabolic syndrome.
    Avgeris M; Kokkinopoulou I; Maratou E; Mitrou P; Boutati E; Scorilas A; Fragoulis EG; Christodoulou MI
    Diabetes Res Clin Pract; 2020 Jun; 164():108187. PubMed ID: 32360711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-based analysis of type-2 diabetes mellitus susceptibility genes identifies specific transcript variants with deregulated expression and association with disease risk.
    Christodoulou MI; Avgeris M; Kokkinopoulou I; Maratou E; Mitrou P; Kontos CK; Pappas E; Boutati E; Scorilas A; Fragoulis EG
    Sci Rep; 2019 Feb; 9(1):1512. PubMed ID: 30728419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization.
    Ortega FJ; Mercader JM; Moreno-Navarrete JM; Rovira O; Guerra E; Esteve E; Xifra G; Martínez C; Ricart W; Rieusset J; Rome S; Karczewska-Kupczewska M; Straczkowski M; Fernández-Real JM
    Diabetes Care; 2014; 37(5):1375-83. PubMed ID: 24478399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Genetic Polymorphisms in MicroRNAs With Type 2 Diabetes Mellitus in a Chinese Population.
    Zhu Z; Zhang Y; Bai R; Yang R; Shan Z; Ma C; Yang J; Sun D
    Front Endocrinol (Lausanne); 2020; 11():587561. PubMed ID: 33628196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 2 Diabetes Mellitus and its comorbidity, Alzheimer's disease: Identifying critical microRNA using machine learning.
    Alamro H; Bajic V; Macvanin MT; Isenovic ER; Gojobori T; Essack M; Gao X
    Front Endocrinol (Lausanne); 2022; 13():1084656. PubMed ID: 36743910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-transcriptional markers associated with clinical complications in Type 1 and Type 2 diabetes mellitus.
    Massaro JD; Polli CD; Costa E Silva M; Alves CC; Passos GA; Sakamoto-Hojo ET; Rodrigues de Holanda Miranda W; Bispo Cezar NJ; Rassi DM; Crispim F; Dib SA; Foss-Freitas MC; Pinheiro DG; Donadi EA
    Mol Cell Endocrinol; 2019 Jun; 490():1-14. PubMed ID: 30926524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis.
    van de Bunt M; Gaulton KJ; Parts L; Moran I; Johnson PR; Lindgren CM; Ferrer J; Gloyn AL; McCarthy MI
    PLoS One; 2013; 8(1):e55272. PubMed ID: 23372846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipocyte precursor cells from first degree relatives of type 2 diabetic patients feature changes in hsa-mir-23a-5p, -193a-5p, and -193b-5p and insulin-like growth factor 2 expression.
    Mirra P; Desiderio A; Spinelli R; Nigro C; Longo M; Parrillo L; D'Esposito V; Carissimo A; Hedjazifar S; Smith U; Formisano P; Miele C; Raciti GA; Beguinot F
    FASEB J; 2021 Apr; 35(4):e21357. PubMed ID: 33710685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study.
    Kong L; Zhu J; Han W; Jiang X; Xu M; Zhao Y; Dong Q; Pang Z; Guan Q; Gao L; Zhao J; Zhao L
    Acta Diabetol; 2011 Mar; 48(1):61-9. PubMed ID: 20857148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying common and specific microRNAs expressed in peripheral blood mononuclear cell of type 1, type 2, and gestational diabetes mellitus patients.
    Collares CV; Evangelista AF; Xavier DJ; Rassi DM; Arns T; Foss-Freitas MC; Foss MC; Puthier D; Sakamoto-Hojo ET; Passos GA; Donadi EA
    BMC Res Notes; 2013 Nov; 6():491. PubMed ID: 24279768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of miR-18a and miR-34c in circulating monocytes associated with vulnerability to type 2 diabetes mellitus and insulin resistance.
    Wang SS; Li YQ; Liang YZ; Dong J; He Y; Zhang L; Yan YX
    J Cell Mol Med; 2017 Dec; 21(12):3372-3380. PubMed ID: 28661068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole blood microRNA levels associate with glycemic status and correlate with target mRNAs in pathways important to type 2 diabetes.
    Mononen N; Lyytikäinen LP; Seppälä I; Mishra PP; Juonala M; Waldenberger M; Klopp N; Illig T; Leiviskä J; Loo BM; Laaksonen R; Oksala N; Kähönen M; Hutri-Kähönen N; Raitakari O; Lehtimäki T; Raitoharju E
    Sci Rep; 2019 Jun; 9(1):8887. PubMed ID: 31222113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-135a-5p overexpression in peripheral blood-derived exosomes mediates vascular injury in type 2 diabetes patients.
    Xie K; Li C; Wang M; Fu S; Cai Y
    Front Endocrinol (Lausanne); 2023; 14():1035029. PubMed ID: 38027164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus.
    Karolina DS; Armugam A; Tavintharan S; Wong MT; Lim SC; Sum CF; Jeyaseelan K
    PLoS One; 2011; 6(8):e22839. PubMed ID: 21829658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA Changes Up to 24 h following Induced Hypoglycemia in Type 2 Diabetes.
    Ramanjaneya M; Bettahi I; Pawar K; Halabi NM; Moin ASM; Sathyapalan T; Abou-Samra AB; Atkin SL; Butler AE
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma microRNA Profiling in Type 2 Diabetes Mellitus: A Pilot Study.
    Tonyan ZN; Barbitoff YA; Nasykhova YA; Danilova MM; Kozyulina PY; Mikhailova AA; Bulgakova OL; Vlasova ME; Golovkin NV; Glotov AS
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
    Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
    J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis.
    Braza-Boïls A; Salloum-Asfar S; Marí-Alexandre J; Arroyo AB; González-Conejero R; Barceló-Molina M; García-Oms J; Vicente V; Estellés A; Gilabert-Estellés J; Martínez C
    Hum Reprod; 2015 Oct; 30(10):2292-302. PubMed ID: 26307093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocyte miRNAs Are Associated With Type 2 Diabetes.
    Parker DC; Wan M; Lohman K; Hou L; Nguyen AT; Ding J; Bertoni A; Shea S; Burke GL; Jacobs DR; Post W; Corcoran D; Hoeschele I; Parks JS; Liu Y
    Diabetes; 2022 Apr; 71(4):853-861. PubMed ID: 35073575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.